Processa Pharmaceuticals, Inc. Common Share Price
NASDAQ: PCSAHealthcare
Live Processa Pharmaceuticals, Inc. Common Share Price Chart
O H L
Processa Pharmaceuticals, Inc. Common Performance Overview
Days Range
▼
$1.85Low
$1.93High
Markets Today
| Previous Close | $1.90 |
|---|---|
| Open | $1.88 |
| Volume | 21,768 |
| Day's Range | $1.85 - $1.93 |
| 52W Range | $1.67 - $14.24 |
| Market Cap | $5.17 M |
Historical Performance
| 1M Returns | -9.52 |
|---|---|
| 3M Returns | -10.38 |
| 6M Returns | -39.87 |
| 1Y Returns | -63.36 |
| 5Y Returns | -99.95 |
| 10Y Returns | NA |
Processa Pharmaceuticals, Inc. Common Fundamentals
| Market Cap | $5.17 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -3.73 |
| EPS TTM | $-5.77 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-13.99 M |
| Profit Margin | N/A |
| Market Cap | $5.17 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -3.73 |
| EPS TTM | $-5.77 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-13.99 M |
| Profit Margin | N/A |
Processa Pharmaceuticals, Inc. Common Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$2.85 M | -$3.95 M | -$3.49 M | -$3.70 M | -$3.33 M | -$2.34 M |
| EBITDA | -$2.85 M | -$3.95 M | -$3.49 M | -$3.70 M | -$3.33 M | -$2.34 M |
| Interest Expense | $0 | $8.86 K | $0 | $0 | $0 | -$2.00 K |
| Depreciation | $301 | $301 | $301 | $301 | $301 | $301 |
| Income Before Tax | -$2.83 M | -$3.93 M | -$3.44 M | -$3.36 M | -$3.38 M | -$3.27 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$2.83 M | -$3.93 M | -$3.44 M | -$3.36 M | -$3.38 M | -$3.27 M |
| Net Profit Margin | - | - | - | - | - | - |
Processa Pharmaceuticals, Inc. Common Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $527 | $4.03 K | $5.29 K | $257 | $269 | $279 |
| Reserve & Surplus | -$90.05 M | -$93.99 M | -$97.42 M | -$100.78 M | -$104.16 M | -$107.43 M |
| Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Liabilities | $1.28 M | $2.07 M | $1.75 M | $2.24 M | $1.98 M | $2.39 M |
| Total Liabilities | $1.28 M | $2.07 M | $1.75 M | $2.24 M | $1.98 M | $2.39 M |
| Fixed Assets | $4.71 K | $4.41 K | $4.11 K | $1.15 M | $3.51 K | $3.21 K |
| Current Assets | $3.76 M | $7.15 M | $6.59 M | $5.67 M | $1.94 M | $2.07 M |
| Total Assets | $4.81 M | $8.18 M | $7.58 M | $7.81 M | $4.52 M | $2.07 M |
Processa Pharmaceuticals, Inc. Common Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$2.83 M | -$3.93 M | -$3.44 M | -$3.36 M | -$3.38 M | -$3.27 M |
| Operating Cash Flow | -$2.73 M | -$2.27 M | -$3.48 M | -$2.90 M | -$3.59 M | -$2.00 M |
| Investing Cash Flow | $0 | $0 | $0 | -$850.00 K | -$500.00 K | $186.00 K |
| Financing Cash Flow | $4.44 M | $6.31 M | $2.86 M | $2.98 M | $244.78 K | $315.17 K |
| Change in Cash | $1.71 M | $4.04 M | -$628.20 K | -$771.47 K | -$3.85 M | -$1.49 M |
Processa Pharmaceuticals, Inc. Common Return Calculator
The Processa Pharmaceuticals, Inc. Common stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5
Invested Amount$10,000
Est. Returns$-9,995
About Processa Pharmaceuticals, Inc. Common
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.
Popular Stocks
FAQs
What is the share price of Processa Pharmaceuticals, Inc. Common today?
Processa Pharmaceuticals, Inc. Common (PCSA) share price as of September 18, 2026 is $1.86. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Processa Pharmaceuticals, Inc. Common?
Yes, Indian Investors can invest in the Processa Pharmaceuticals, Inc. Common (PCSA) Share by opening an international trading account with Angel One.
How can I purchase Processa Pharmaceuticals, Inc. Common shares in India?
Purchasing Processa Pharmaceuticals, Inc. Common (PCSA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Processa Pharmaceuticals, Inc. Common (PCSA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Processa Pharmaceuticals, Inc. Common?
Yes, you can purchase fractional shares of Processa Pharmaceuticals, Inc. Common (PCSA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Processa Pharmaceuticals, Inc. Common?
The market capitalization of Processa Pharmaceuticals, Inc. Common on September 18, 2026, is $5.17 M.
In which sector Processa Pharmaceuticals, Inc. Common belongs?
Processa Pharmaceuticals, Inc. Common operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Processa Pharmaceuticals, Inc. Common stocks?
In order to invest in Processa Pharmaceuticals, Inc. Common (PCSA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
